Literature DB >> 2804031

The Briard dog: a new animal model of congenital stationary night blindness.

K Narfström1, A Wrigstad, S E Nilsson.   

Abstract

Congenital stationary night blindness (CSNB), apparently inherited in an autosomal recessive manner, was observed in a litter of Briard dogs in Sweden. Of nine litter mates five had nyctalopia. The results of different clinical tests, including electroretinography (ERG), were compared with the results found in four human cases of CSNB, three of which were most probably associated with autosomal recessive inheritance and one with X-linked inheritance. The congenital and stationary nature of the disease, ophthalmoscopically normal appearing fundi, and recordable but reduced photopic flicker responses were some of the similarities found between canine and human cases. The single-flash ERG response was abnormal in the humans as well as in the affected Briards. However, the human cases showed a "negative' ERG, whereas in the Briards both the a and b waves were extremely reduced and present only at a photopic level. Cases similar to these Briards have been described also in man, where rhodopsin concentration and regeneration were found to be normal, suggesting a disturbed transduction mechanism. It thus appears that the Briard dog may become a valuable model of human CSNB.

Entities:  

Mesh:

Year:  1989        PMID: 2804031      PMCID: PMC1041872          DOI: 10.1136/bjo.73.9.750

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Electroretinography in cases of night blindness.

Authors:  L A RIGGS
Journal:  Am J Ophthalmol       Date:  1954-07       Impact factor: 5.258

2.  [Analysis of the human electroretinogram].

Authors:  G SCHUBERT; H BORNSCHEIN
Journal:  Ophthalmologica       Date:  1952-06       Impact factor: 3.250

3.  Congenital stationary night blindness: an animal model.

Authors:  D A Witzel; E L Smith; R D Wilson; G D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-08       Impact factor: 4.799

4.  Changes in the electroretinogram and visual evoked potentials during general anaesthesia.

Authors:  C Raitta; U Karhunen; A M Seppälainen; M Naukkarinen
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-08

5.  Congenital stationary night blindness with myopia: a clinico-pathologic study.

Authors:  I Watanabe; Y Taniguchi; K Morioka; M Kato
Journal:  Doc Ophthalmol       Date:  1986-06-16       Impact factor: 2.379

6.  Congenital stationary night blindness with negative electroretinogram. A new classification.

Authors:  Y Miyake; K Yagasaki; M Horiguchi; Y Kawase; T Kanda
Journal:  Arch Ophthalmol       Date:  1986-07

7.  Congenital stationary nightblindness.

Authors:  R E Carr
Journal:  Trans Am Ophthalmol Soc       Date:  1974

8.  An electrophysiological and psychophysical study of two forms of congenital night blindness.

Authors:  E Auerbach; V Godel; H Rowe
Journal:  Invest Ophthalmol       Date:  1969-06

9.  Rhodopsin and the electrical activity of the retina in congenital night blindness.

Authors:  R E Carr; H Ripps; I M Siegel; R A Weale
Journal:  Invest Ophthalmol       Date:  1966-10

10.  Cone dark adaptation: the influence of halothane anesthesia.

Authors:  D van Norren; P Padmos
Journal:  Invest Ophthalmol       Date:  1975-03
View more
  32 in total

Review 1.  Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies.

Authors:  F Hafezi; C Grimm; B C Simmen; A Wenzel; C E Remé
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.

Authors:  Defne Amado; Federico Mingozzi; Daniel Hui; Jeannette L Bennicelli; Zhangyong Wei; Yifeng Chen; Erin Bote; Rebecca L Grant; Jeffrey A Golden; Kristina Narfstrom; Nasreen A Syed; Stephen E Orlin; Katherine A High; Albert M Maguire; Jean Bennett
Journal:  Sci Transl Med       Date:  2010-03-03       Impact factor: 17.956

Review 3.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

Review 4.  Genetic and phenotypic variations of inherited retinal diseases in dogs: the power of within- and across-breed studies.

Authors:  Keiko Miyadera; Gregory M Acland; Gustavo D Aguirre
Journal:  Mamm Genome       Date:  2011-11-08       Impact factor: 2.957

Review 5.  The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.

Authors:  Eric A Pierce; Jean Bennett
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 6.  The function of dog models in developing gene therapy strategies for human health.

Authors:  Keri L Nowend; Alison N Starr-Moss; Keith E Murphy
Journal:  Mamm Genome       Date:  2011-07-06       Impact factor: 2.957

7.  Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina.

Authors:  B Ameline; K-T Tshilenge; M Weber; M Biget; L Libeau; R Caplette; A Mendes-Madeira; N Provost; C Guihal; S Picaud; P Moullier; V Pichard; T Cronin; C Isiegas
Journal:  Gene Ther       Date:  2017-09-07       Impact factor: 5.250

8.  Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.

Authors:  Jeannette Bennicelli; John Fraser Wright; Andras Komaromy; Jonathan B Jacobs; Bernd Hauck; Olga Zelenaia; Federico Mingozzi; Daniel Hui; Daniel Chung; Tonia S Rex; Zhangyong Wei; Guang Qu; Shangzhen Zhou; Caroline Zeiss; Valder R Arruda; Gregory M Acland; Lou F Dell'Osso; Katherine A High; Albert M Maguire; Jean Bennett
Journal:  Mol Ther       Date:  2008-01-22       Impact factor: 11.454

9.  Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.

Authors:  Artur V Cideciyan; Samuel G Jacobson; William A Beltran; Alexander Sumaroka; Malgorzata Swider; Simone Iwabe; Alejandro J Roman; Melani B Olivares; Sharon B Schwartz; András M Komáromy; William W Hauswirth; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

10.  Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.

Authors:  Jonathan B Jacobs; Louis F Dell'Osso; Zhong I Wang; Gregory M Acland; Jean Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.